Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationships

Journal of Cancer Research and Therapeutics

Volumn 10, Issue , 2014, Pages C167-C172

  Hao, Jun Feng ^a   Ren, Kai Ming ^a   Bai, Jiu Xu ^a   Wang, Shou Nan ^a   Shao, Bing ^a   Cao, Ning ^a   Li, Xu ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Clear cell renal cell carcinoma; microRNS; miRNA mRNA dysregulation; pathway

Indexed keywords

ALDOSTERONE; ARGININE; MESSENGER RNA; MICRORNA; MICRORNA 136; MICRORNA 320D; MICRORNA 335; MICRORNA 340; MICRORNA 425; PROLINE; UNCLASSIFIED DRUG; TUMOR MARKER;

AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; GENE REGULATORY NETWORK; HUMAN; KIDNEY CARCINOMA; MIRNA MESSENGER RNA PATHWAY; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; RNA EXTRACTION; SODIUM ABSORPTION; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS;

CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; OXIDATIVE PHOSPHORYLATION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84916599749     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.145856     Document Type: Article

References (47)

1. Boorjian S. Commentary on reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL 3rd, Hofmann JN, Chow WH, Purdue MP, Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD. Am J Epidemiol 2013;177:1368-77.
2. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7:245-57.
3. Janout V, Janoutová G. Epidemiology and risk factors of kidney cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004;148:95-101.
4. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373:1119-32.
5. Huang Y, Dai Y, Yang J, Chen T, Yin Y, Tang M, et al. Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol 2009;35:1119-23.
6. DeVere White RW, Vinall RL, Tepper CG, Shi XB. MicroRNAs and their potential for translation in prostate cancer. Urol Oncol 2009;27:307-11.
7. Calin GA, Croce CM. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 2006;66:7390-4.
8. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004.
9. Liu J, Zhong X, Li J, Liu B, Guo S, Chen J, et al. Screening and identification of lung cancer metastasis-related genes by suppression subtractive hybridization. Thorac Cancer 2012;3:207-16.
10. Nurwidya F, Takahashi F, Takahashi K. Meeting Report: Current Cancer Perspectives from the 9th Annual Meeting of the Japanese Society of Medical Oncology. Thorac Cancer 2012;3:94-7.
11. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
12. Bhatt K, Mi QS, Dong Z. microRNAs in kidneys: Biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 2011;300:F602-10.
13. Miyoshi K, Miyoshi T, Siomi H. Many ways to generate microRNA-like small RNAs: Non-canonical pathways for microRNA production. Mol Genet Genomics 2010;284:95-103.
14. Yang JS, Lai EC. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell 2011;43:892-903.
15. Bai XY, Ma Y, Ding R, Fu B, Shi S, Chen XM. MiR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol 2011;22:1252-61.
16. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007;25:387-92.
17. Yi Z, Fu Y, Zhao S, Zhang X, Ma C. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 2010;136:855-62.
18. White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumour?suppressor effect for miR?215. Br J Cancer 2011;105:1741?9.
19. Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, et al. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS One 2012;7:e38298.
20. Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y, et al. Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One 2010;5:e15224.
21. Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM. The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 2010;8:64.
22. Zhai Q, Zhou L, Zhao C, Wan J, Yu Z, Guo X, et al. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun 2012;419:621-6.
23. Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Chang I, et al. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis 2012;33:294-300.
24. Sakurai T, Bilim VN, Ugolkov AV, Yuuki K, Tsukigi M, Motoyama T, et al. The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells. Biochem Biophys Res Commun 2012;422:607-14.
25. Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma. Oncotarget 2012;3:44-57.
26. Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, et al. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 2011;71:6208-19.
27. Drake KM, Ruteshouser EC, Natrajan R, Harbor P, Wegert J, Gessler M, et al. Loss of heterozygosity at 2q37 in sporadic Wilms tumor: Putative role for miR?562. Clin Cancer Res 2009;15:5985?92.
28. Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol 2011;59:721-30.
29. Powers MP, Alvarez K, Kim HJ, Monzon FA. Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping. Diagn Mol Pathol 2011;20:63-70.
30. Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, et al. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 2010;12:687-96.
31. Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, et al. Identifying mRNA targets of microRNA dysregulated in cancer: With application to clear cell Renal Cell Carcinoma. BMC Syst Biol 2010;4:51.
32. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
33. Xu J, Li CX, Lv JY, Li YS, Xiao Y, Shao TT, et al. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: Case study of prostate cancer. Mol Cancer Ther 2011;10:1857-66.
34. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011;39:D561-8.
35. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
36. Arora P, Wu C, Khan AM, Bloch DB, Davis?Dusenbery BN, Ghorbani A, et al. Atrial natriuretic peptide is negatively regulated by microRNA?425. J Clin Invest 2013;123:3378?82.
37. Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet 2013;9:e1003311.
38. Peng WZ, Ma R, Wang F, Yu J, Liu ZB. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci 2014;15:4031-48.
39. Rio-Machin A, Ferreira BI, Henry T, Gómez-López G, Agirre X, Alvarez S, et al. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype. Leukemia 2013;27:925-31.
40. Wojcicka A, Piekielko-Witkowska A, Kedzierska H, Rybicka B, Poplawski P, Boguslawska J, et al. Epigenetic regulation of thyroid hormone receptor beta in renal cancer. PLoS One 2014;9:e97624.
41. Wu PY, Zhang XD, Zhu J, Guo XY, Wang JF. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone. Hum Pathol 2014;45:1664-73.
42. Yang Y, Wu J, Guan H, Cai J, Fang L, Li J, et al. MiR?136 promotes apoptosis of glioma cells by targeting AEG?1 and Bcl?2. FEBS Lett 2012;586:3608?12.
43. Chen W, Yang Y, Chen B, Lu P, Zhan L, Yu Q, et al. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. J Neurooncol 2014;120:43-53.
44. Zhang Q, Xiao X, Li M, Li W, Yu M, Zhang H, et al. Telmisartan improves kidney function through inhibition of the oxidative phosphorylation pathway in diabetic rats. J Mol Endocrinol 2012;49:35-46.
45. Small DM, Morais C, Coombes JS, Bennett NC, Johnson DW, Gobe GC. Oxidative stress-induced alterations in PPAR-? and associated mitochondrial destabilization contribute to kidney cell apoptosis. Am J Physiol Renal Physiol 2014;307:F814-22.
46. Takeyama H, Yamamoto H, Yamashita S, Wu X, Takahashi H, Nishimura J, et al. Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer. Mol Cancer Ther 2014;13:976-85.
47. Zhou X, Wei M, Wang W. MicroRNA?340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res Commun 2013;437:653?8.